SCHEMBL8922387

SCHEMBL8922387

COC(=O)c1ccc(CCCSCC(=O)Nc2cc(Cl)cc(Cl)c2C(=O)OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
LMNA P02545 2/20 0.50
CYP4A11 Q02928 2/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYP4F2 P78329 1/20 0.43
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8923079 0.91 ALDH1A1 (0.43) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8920748 0.91 KMT2A (0.44) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8921264 0.89 CYP4F2 (0.47) MAPTMEN1KMT2ALMNACYP4A11
SCHEMBL8921852 0.85 POLB (0.44) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8919875 0.85 ALDH1A1 (0.40) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8923389 0.81 ALDH1A1 (0.43) MEN1KMT2ALMNAALDH1A1KDM4E
SCHEMBL8921973 0.81 KMT2A (0.39) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8924828 0.81 SMN1; SMN2 (0.43) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL8922395 0.79 CYP4A11 (0.47) MAPTMEN1KMT2ALMNACYP4A11
SCHEMBL8921188 0.78 KMT2A (0.46) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5633379-A N-METHYLASPARTIC ACID ANTAGONIST CIBA-GEIGY CORPORATION (US) 1997-05-27 US disclosed